VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
QNTM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
QNTMQuantum BioPharma Ltd.
$3.44$15M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksQNTMQuarterly Financials

Quantum BioPharma Ltd. (QNTM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Quantum BioPharma Ltd. (QNTM) quarterly income statement — complete revenue, gross profit & net income history

QNTM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold125.67K0000000000000000000
COGS % of Revenue--------------------
Gross Profit-125.67K0000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses2.74M-7.95M4.75M4.85M3.4M6.24M4.18M3.46M2.26M1.8M3.31M8.83M9.84M6.66M7.25M7.87M5.65M6.12M5.13M12.69M
OpEx % of Revenue--------------------
Selling, General & Admin2.13M2.16M4.02M4.22M1.61M1.69M3.21M2.44M1.97M1.81M2.69M2.74M5.92M2.81M4.24M4.83M3.86M4.16M4.24M8.09M
SG&A % of Revenue--------------------
Research & Development617.42K70.4K495.22K549.2K1.65M4.28M744.8K897.99K160.26K-29.96K-32.98K1.61M2.31M2.69M1.87M1.41M937.05K852.39K-107.26K3.61M
R&D % of Revenue--------------------
Other Operating Expenses0-1000K234.74K81.03K141.49K267.22K228.77K122.53K124.28K21.98K658.92K1000K1000K1000K1000K1000K851.66K1000K1000K982.35K
Operating Income-2.87M7.95M-4.75M-4.85M-3.4M-6.24M-4.18M-3.46M-2.26M-1.8M-3.31M-8.83M-9.84M-6.66M-7.25M-7.87M-5.65M-6.12M-5.13M-12.69M
Operating Margin %--------------------
Operating Income Growth %15.55%227.4%-13.55%-40.41%-50.5%-246.52%-26.24%60.86%77.07%72.96%54.35%-12.27%-74.26%-8.84%-41.33%38.01%42.37%-1.61%60.98%-93.75%
EBITDA-2.74M8.08M-4.6M-4.71M-3.27M-6.13M-4.06M-3.32M-2.14M-1.68M-3.17M-7.72M-8.72M-5.51M-6.11M-6.73M-4.55M-5.01M-4.13M-11.71M
EBITDA Margin %--------------------
EBITDA Growth %16.04%231.86%-13.35%-41.94%-52.9%-265.02%-28.28%57.02%75.48%69.5%48.18%-14.72%-91.6%-9.86%-47.97%42.49%48.61%0.96%66.13%-125.09%
D&A (Non-Cash Add-back)125.67K129.37K145.34K141.38K129.69K112.8K120.81K136.81K120.14K122.22K146.81K1.11M1.13M1.15M1.15M1.13M1.1M1.11M1M982.35K
EBIT-2.87M-3.78M-4.64M-9.53M-8.39M-5.44M-4M-3.34M-2.08M-1.65M-2.8M-5.49M-9.36M-6.66M-7.25M-7.95M-5.44M-6.13M-5.61M-12.74M
Net Interest Income-44.56K0-4.66K-144.84K-283.4K115.64K153.5K96.07K160.11K153.78K174.07K186.16K271.67K299.88K49.45K-14.04K-16.38K-29.2K-1.96K-18.92K
Interest Income00100.42K90.73K67.22K132.07K163.87K104.42K172.52K153.79K174.07K186.16K272.34K300.02K65.5K2.22K0000
Interest Expense44.56K0105.08K235.57K350.62K16.43K10.37K8.36K12.41K120066713516.05K16.25K16.38K29.2K1.96K18.92K
Other Income/Expense-10.69M-11.65M0-4.91M-5.34M784.95K165.74K104.11K165.93K149.56K2.18M3.34M-112.55K511.33K125.28K-99.5K188.84K-44.16K-482.2K-64.98K
Pretax Income-13.56M-3.7M-4.75M-9.77M-8.74M-5.46M-4.02M-3.35M-2.09M-1.65M-1.13M-5.49M-9.96M-6.15M-7.13M-7.97M-5.46M-6.16M-5.61M-12.75M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-13.37M-3.03M-5.32M-9.25M-8.58M-5.36M-3.83M-3.11M-1.9M-1.32M-1.06M-5.49M-9.96M-6.15M-7.13M-4.42M-5.91M-6.35M-5.79M-13.21M
Net Margin %--------------------
Net Income Growth %-55.92%43.54%-38.98%-197.34%-350.61%-305.11%-261.11%43.32%80.89%78.48%85.13%-24.1%-68.62%3.14%-23.1%66.5%40.59%-44.98%57.32%-116.76%
Net Income (Continuing)-13.56M-3.7M-4.75M-9.77M-8.74M-5.46M-4.02M-3.35M-2.09M-1.65M-1.13M-5.49M-9.96M-6.15M-7.13M-7.97M-5.46M-6.16M-5.61M-12.75M
Discontinued Operations0000000000000001000K-444.51K-184.59K-176.1K-452.94K
Minority Interest-2.02M-1.82M-1.15M-1.72M-1.2M-1.04M-944.29K-756.13K-515.55K-327.5K-89.53K000000000
EPS (Diluted)-2.98-0.79-1.40-3.23-7.52-5.22-4.17-4.85-3.12-2.18-1.76-9.10-16.61-10.29-12.13-7.47-9.60-11.01-10.37-23.85
EPS Growth %60.37%84.87%66.43%33.4%-141.03%-139.45%-136.93%46.7%81.22%78.81%85.49%-21.82%-73.02%6.54%-16.97%68.68%60.03%27.8%85.09%26.07%
EPS (Basic)-2.98-0.79-1.40-3.23-7.52-5.22-4.17-4.85-3.12-2.18-1.76-9.10-16.61-10.29-12.13-7.47-9.60-11.01-10.37-23.85
Diluted Shares Outstanding4.49M3.89M3.8M3.02M1.14M1.03M917.85K641.16K610.03K606.01K602.96K603.6K599.42K597.65K587.78K591.99K615.37K576.49K558.4K553.72K
Basic Shares Outstanding4.49M3.89M3.8M3.02M1.14M1.03M917.85K641.16K610.03K606.01K602.96K603.6K599.42K597.65K587.78K591.99K615.37K576.49K558.4K553.72K
Dividend Payout Ratio--------------------